Vitiligo Severity, Quality of Life, Work Productivity and Activity Impairment
Launched by ASSIUT UNIVERSITY · Mar 10, 2025
Trial Information
Current as of May 09, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on understanding how vitiligo, a skin condition that causes loss of skin color, affects people's lives. Researchers will translate a special questionnaire, called the Vitiligo Specific Quality of Life (VITIQOL), into Arabic to help Arabic-speaking patients share their experiences. They will also assess how vitiligo impacts work productivity and daily activities through another questionnaire. The study aims to find out how the severity and location of vitiligo on the body can influence a patient's quality of life.
To participate in this trial, you need to be an adult aged 18 to 60 who has been diagnosed with vitiligo by a doctor and can speak Arabic. Participants will be asked to complete surveys about their health and daily life. This trial is not yet recruiting, but it will provide valuable insights into how vitiligo affects individuals, which could help improve care and support for patients in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adults \> 18 years and less than 60 years old diagnosed with vitiligo by a physician Patients willing to complete the survey questionnaires Patients who can speak Arabic
- Exclusion Criteria:
- • Patients with other major skin disease affecting QOL . Patient with chronic diseases as diabetes mellitus and hypertension Not working patients
About Assiut University
Assiut University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that enhance healthcare outcomes. With a strong emphasis on innovation and collaboration, the university engages in a wide array of clinical studies across various disciplines, aiming to contribute valuable insights into disease prevention, diagnosis, and treatment. Assiut University's commitment to ethical research practices and rigorous scientific methodology ensures the integrity and reliability of its clinical trials, ultimately benefiting both the local community and the global medical landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Esraa Sa Ahmed, Resident
Principal Investigator
Assiut University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported